Figure 1
From: Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
EpCAM expression is associated with the proliferation and metastatic potential of PC3 cells. A) The proliferation rates of EpCAM+, EpCAM−, and unsorted PC3 cells were determined with a CCK-8 assay. Statistical analysis was performed using a two-way ANOVA. B) The expression of EpCAM on PC3 and PC3M cells was determined by staining the cells with a PE-conjugated anti-EpCAM antibody.